Jane Street
PLRX icon

Jane Street’s Pliant Therapeutics PLRX Stock Holding History

Jane Street’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.6K Buy
+61,900
New +$75.4K ﹤0.01% 10780
2023
Q2 		– Sell
-29,200
Closed -$777K – 9373
2023
Q1 		$777K Buy
29,200
+16,900
+137% +$481K ﹤0.01% 5503
2022
Q4 		$238K Sell
12,300
-9,200
-43% -$192K ﹤0.01% 7397
2022
Q3 		$449K Buy
+21,500
New +$411K ﹤0.01% 6880

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Jane Street's PLRX Position: Q2 2026 in Review

Jane Street reduced its Pliant Therapeutics (PLRX) stake by 64% in Q2 2026, selling an estimated $276K and leaving 129,951 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #10359.

Jane Street first reported a position in PLRX in Q2 2020 and has held it in 16 quarters since. The position peaked at $5.92M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Jane Street held 129,951 shares of Pliant Therapeutics worth $148K as of Q2 2026.
  • Jane Street sold 226,843 Pliant Therapeutics shares in Q2 2026, an estimated $276K.
  • Pliant Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10359 holding.
  • Jane Street first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Jane Street's Pliant Therapeutics position peaked at $5.92M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.